Have a personal or library account? Click to login
Plasma Homocysteine Level And C677T Polymorphism In MTHFR Gene In Patients With Acute Coronary Syndrome Cover

Plasma Homocysteine Level And C677T Polymorphism In MTHFR Gene In Patients With Acute Coronary Syndrome

Journal of Biomedical and Clinical Research
Volume 8 (2015): Issue 1 (June 2015)
By: Andrey V. Grek,  Lyudmyla N. Prystupa and  Tatiana V. Sytnik  
Open Access
|Dec 2015

References

  1. 1. World Health Organization [Internet]. Geneva: Global status report on noncommunicable diseases 2010. [updated 2011 Apr; cited 2014 Dec 9]. Available from: http://www.who.int/nmh/publications/ncd_report2010/en/.
    Search in Google Scholar
  2. 2. Gorbas IM, Barna OM, Sakalosh VY, Bakumenko MA. [Estimated prevalence and control of risk factors for cardiovascular disease in the population and physicians]. Liky Ukrainy. 2010;(1):24-6. Ukrainian.
    Search in Google Scholar
  3. 3. Gaydaev YO, Kornatchkyi VM. [Health problems and directions of its improvement in modern conditions]. Ukr. Kardiol. J. 2007;(5):7. Ukrainian.
    Search in Google Scholar
  4. 4. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med, 2006,3(11):e 442.10.1371/journal.pmed.0030442166460117132052
    Search in Google Scholar
  5. 5. Spagnoli LG, Bonnano E., Sangiorgi G, Mauriello A. Role of inflammation in atherosclerosis. J Nucl Med. 200748(11):1800-15.10.2967/jnumed.107.03866117942804
    Search in Google Scholar
  6. 6. Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr rev. 2007;65(12 Pt 2):140-6.10.1301/nr.2007.dec.S140-S146
    Search in Google Scholar
  7. 7. Shan P.K. Molecular mechanisms of plaque instability. Curr Opin Lipidol. 2007;18(5):492-9.10.1097/MOL.0b013e3282efa32617885418
    Search in Google Scholar
  8. 8. Sumagin R, Sarelius I. A role for ICAM−1 in maintenance of leucocite−endothelial cell rolling interactions in inflammed arteries. Am J Physiol Heart Circ Physiol. 2007;293(5):H2786-98.10.1152/ajpheart.00720.200717704289
    Search in Google Scholar
  9. 9. Pereira IA, Borba EF. The role of inflammation, humoral and cell mediated autoimmunity in the pathogenesis of atherosclerosis. Swiss Med Wkly. 2008;138(37-38):534-9.
    Search in Google Scholar
  10. 10. Stancu CS, Toma L, Sima AV. Dual role of lipoproteins in endothelial cell dysfunction in atherosclerosis. Cell Tissue Res. 2012;349(2):433-46.10.1007/s00441-012-1437-122592627
    Search in Google Scholar
  11. 11. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-41.10.1038/35025203282622211001066
    Search in Google Scholar
  12. 12. Etsuo N. Do free radicals play causal role in atherosclerosis? Low density lipoprotein oxidation and vitamin E revisited. J Clin Biochem Nutr. 2011;48(1):3-7.
    Search in Google Scholar
  13. 13. Griendling KK, Alexander RW. Oxidative stress and cardiovascular disease. Circulation. 1997;96(10): 3264-5.
    Search in Google Scholar
  14. 14. Watson C, Nicholas J. ALP. Role of Chlamydia pneumoniae in atherosclerosis. Clin Sci. 2008;114:509-31.10.1042/CS2007029818336368
    Search in Google Scholar
  15. 15. Jackson LA, Campbell LA, Schmidt RA, Kuo CC, Cappuccio AL, Lee MJ, et al. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol. 1997;150(5):1785-90.
    Search in Google Scholar
  16. 16. McCully KS. Vascular pathology of homocysteinemia: implications for the pathogenesis of atherosclerosis. Am J Pathol. 1969;56(1):111-28.
    Search in Google Scholar
  17. 17. McDowell IF, Lang D. Homocysteine and endothelial dysfunction: a link with cardiovascular disease. J Nutr. 2000;130(2S Suppl):369S-72S.10.1093/jn/130.2.369S10721909
    Search in Google Scholar
  18. 18. Austin RC, Lentz SR, Werstuck GH. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease. Cell Death Differ. 2004;11 Suppl 1:S56-64.10.1038/sj.cdd.440145115243582
    Search in Google Scholar
  19. 19. AbdulleAM, Pathan JY, Moussa N, Gariballa S. Association between homocysteine and endothelial dysfunction markers in stroke disease. Nutr Neurosci. 2010;13(1):2-6.10.1179/147683010X12611460763562
    Search in Google Scholar
  20. 20. Verhoef P, Stampfer MJ. Prospective studies of homocysteine and cardiovascular disease. Nutr Rev. 1995;53910):283-8.10.1111/j.1753-4887.1995.tb01478.x
    Search in Google Scholar
  21. 21. Stampfer M, Malinow M. Can lowering homocysteine levels reduce cardiovascular risk? N Engl J Med. 1995;33295):328-9.10.1056/NEJM199502023320511
    Search in Google Scholar
  22. 22. Graham M, Daly L, Refsum H, Robinson K, Brattström LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease: the European concerted action project. JAMA. 1997;277(22):1775-81.10.1001/jama.1997.03540460039030
    Search in Google Scholar
  23. 23. Mayer E, Jacobsen D, Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol. 1996;27(3):517-27.10.1016/0735-1097(95)00508-0
    Search in Google Scholar
  24. 24. Hankey GJ, Eikelboom JW. Homocysteine and vascular disease. Lancet. 1999;354(9176):407-13.10.1016/S0140-6736(98)11058-9
    Search in Google Scholar
  25. 25. Burtina IY. [Effect of the composite preparation Cardonat on plasma homocysteine level in patients with coronary artery disease]. Ukrain Med. Chasopis. 2005;1(45): 45-8. Russian.
    Search in Google Scholar
  26. 26. Blacher J, Benetos A, Kirzin J, Malmejac A, Guize L, Safar ME. Relation of plasma homocysteine to cerebrovascular mortality in a French population. Am J Cardiol. 2002;90(6):591-5.10.1016/S0002-9149(02)02561-4
    Search in Google Scholar
  27. 27. Ciaccio M, Bivona G, Bellia C. Therapeutical approach to plasma homocysteine and cardiovascular risk reduction. Ther Clin Risk Manag. 2008;4(1):219-24.10.2147/TCRM.S1807250365718728711
    Search in Google Scholar
  28. 28. Trabetti E. Homocysteine, MTHFR gene polymorphisms, and cardio-cerebrovascular risk. J Appl Genet. 2008;49(3):267-82.10.1007/BF0319562418670064
    Search in Google Scholar
  29. 29. Bjelland I, Tell GS, Vollset SE, Refsum H, Ueland PM. Folate, vitamin B12, homocysteine, and the MTHFR 677C->T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry. 2003;60(6):618-26.10.1001/archpsyc.60.6.61812796225
    Search in Google Scholar
  30. 30. Bailey LB, Gregory JF 3rd. Polymorphisms of methylenetetrahydrofolate reductase and other enzymes: metabolic significance, risks and impact on folate requirement. J Nutr. 1999;129(5):919-22.10.1093/jn/129.5.91910222379
    Search in Google Scholar
  31. 31. Martin YN, Salavaggione OE, Eckloff BW, Wieben ED, Schaid DJ, Weinshilboum RM. Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomics. Pharmacogenetics and Genomics. 2006;16(4):265-77.10.1097/01.fpc.0000194423.20393.0816538173
    Search in Google Scholar
  32. 32. Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, et al. Consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins incardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med. 2003;41:1392-403.10.1515/CCLM.2003.21414656016
    Search in Google Scholar
  33. 33. Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337(4):230-36.10.1056/NEJM1997072433704039227928
    Search in Google Scholar
  34. 34. Oudi ME, Aouni Z, Mazigh C, Khochkar R, Gazoueni E, Haouela H, et al. Homocysteine and markers of inflammation in acute coronary syndrome. Exp Clin Cardiol. 2010;15(2):e25-28.
    Search in Google Scholar
  35. 35. Haynes WG. Hyperhomocysteinemia, vascular function and atherosclerosis: effects of vitamins. Cardiovasc Drug Ther. 2002;16(5):391-9.10.1023/A:1022130217463
    Search in Google Scholar
  36. 36. Keijzer MB, den Heijer M, Blom HJ, Bos GM, Willems HP, Gerrits WB, et al. Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolate-reductase (MTHFR) and inherited thrombophilic factors in venous thromboembolism. Thromb Haemost. 2002;88(5):723-8.10.1055/s-0037-1613292
    Search in Google Scholar
  37. 37. Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost. 2005;3(2):292-9.10.1111/j.1538-7836.2005.01141.x15670035
    Search in Google Scholar
  38. 38. Frederiksen J, Juul K, Grande P, Jensen GB, Schroeder TV, Tybjaerg-Hansen A, et al. Methylenetetrahydrofolate reductase polymorphism (C677T), hyperhomocysteinemia, and risk of ischemic cardiovascular disease and venous thromboembolism: prospective and case-control studies from the Copenhagen City Heart Study. Blood. 2004;104:3046-51.10.1182/blood-2004-03-089715226189
    Search in Google Scholar
  39. 39. Brattström L, Wilcken DE, Ohrvik J, Brudin L. Common methylenetetrahydrofolate reductase gene mutation leads to hyperhomocysteinemia but not to vascular disease: the result of a meta-analysis. Circulation. 1998;98(23):2520-6.10.1161/01.CIR.98.23.25209843457
    Search in Google Scholar
  40. 40. Martin YN, Salavaggione OE, Eckloff BW, Wieben ED, Schaid DJ, Weinshilboum RM. Human methylenetetrahydrofolate reductase pharmacogenomics: gene resequencing and functional genomics. Pharmacogenet Genomics. 2006;16:265-77.10.1097/01.fpc.0000194423.20393.08
    Search in Google Scholar
  41. 41. Xu H, Liu C, Wang Q. Plaque image characteristics, hyperhomocysteinemia, and gene polymorphism of homocysteine metabolism-related enzyme (MTHFR C677T) in acute coronary syndrome. Cell Biochem Biophys. 2013;66(2): P. 403-7.10.1007/s12013-012-9483-623314883
    Search in Google Scholar
DOI: https://doi.org/10.1515/jbcr-2015-0151 | Journal eISSN: 1313-9053
Journal RSS Feed
Language: English
Page range: 46 - 51
Submitted on: Feb 2, 2015
|
Accepted on: May 18, 2015
|
Published on: Dec 10, 2015
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
MTHFR,
acute coronary syndrome,
cardiovascular diseases,
homocysteine
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Ophthalmology,
Public health,
Pharmacy,
Clinical pharmacy

© 2015 Andrey V. Grek, Lyudmyla N. Prystupa, Tatiana V. Sytnik, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 8 (2015): Issue 1 (June 2015)Next article